SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (328)1/5/2001 1:14:08 AM
From: tuck  Read Replies (1) | Respond to of 1784
 
Looks like a Trickle high flier is in a little trouble:

biz.yahoo.com

The loser would appear to be ABI. What's a portfolio manager to do? Anybody got an idea of what might happen here? I would think ABI will have to take a hit on earnings as a result of licensing the technology from APBiotech. Or would ABI have to pay a lump sum judgment? Or appeal? And how much is this dye technology worth?

Wondering if I should double down as threatened if it tanks. Doesn't seem to have traded after hours.

Cheers, Tuck